Back to Directory

BIM-23052

Growth Hormone Secretagogues

Ghrelin receptor agonist being studied for growth hormone deficiency and cachexia.

Key Benefits

  • ✓GH stimulation
  • ✓Appetite enhancement
  • ✓Under investigation for GHD

Dosing Information

Dosage Range
Research stage
Frequency
Under investigation
Typical Duration
Investigational

Detailed Protocol

Research compound. Protocols under investigation. Not available for general use.

About BIM-23052

BIM-23052 is an investigational ghrelin mimetic being studied for growth hormone deficiency and conditions requiring appetite stimulation. Research stage compound with limited available data.

Research Notes

Research compound being developed for GH deficiency and cachexia. Limited published data available.

Get Peptide Research Updates

Newsletter signup

Please wait...

Thanks for signing up! You will receive an email to confirm your subscription.

Potential Side Effects

  • •Under investigation

Always consult with a healthcare professional before starting any peptide therapy.